Team Approach | Innovative Treatment | Leading Edge Research
Pioneering Program, Team Approach
NorthShore has one of the largest brain and spine tumor programs in the country, providing experienced and compassionate brain tumor care backed by leading research and an expert team of multidisciplinary specialists. Our neuro-oncology and neurosurgery specialists work in tandem to develop customized treatment plans for brain tumors—whether medical, surgical or both—that will yield the best outcomes for patients.
Our experts have vast experience with a wide range of tumor types, ranging from:
- Primary brain tumors (ones that originate in the brain)
- Meningiomas (tumors on the surface of the brain)
- Metastatic tumors (tumors that spread to the brain through the bloodstream from the body.
NorthShore Neurological Institute understands that tumors of the spine, pituitary and brain are as individual as the patients they affect. That’s why our nationally-recognized brain tumor and spine tumor program offers the most advanced care available—tailored to the individualized needs of each and every patient. Our neurological specialists work closely with experts from our Kellogg Cancer Center in radiology, medical oncology, nursing, social work and rehab medicine to give our patients the advantage of an entire team of caregivers. And with NorthShore’s award-winning electronic medical record, your care team’s collaboration is seamless.
Innovative Treatment for Brain Tumors
At NorthShore, we evaluate brain tumors utilizing the latest in diagnostic technology. High resolution magnetic resonance imaging (MRI) is the primary method for diagnosing brain tumors; CT and nuclear medicine imaging tools are also used. On-site scanning allows for rapid review by a specialized neuroradiology physician and timely communication with patients about results.
The initial treatment for brain tumors often begins with biopsy or resection of the brain tumor with the goal of preserving neurologic function. Our nationally-recognized, fellowship-trained neurosurgeons use a variety of advanced, minimally invasive brain surgery technologies, including:
- Synaptive: This innovative, robotic technology improves access, precision and visualization of brain tumors, allowing neurosurgeons to remove previously inoperable tumors. NorthShore is currently the only institution in the Chicago area with this technology.
- NICO BrainPath: This technology allows our surgeons to navigate through the natural contours of the brain transsulcal, minimizing damage to the surrounding tissue, with specially-designed instruments.
- Visualase Laser Thermal Ablation: NorthShore was the first institution in Chicago to utilize this technique—heat from an ultra-thin laser reduces damaged tissue in minutes and leaves only a small incision while obliterating the tumor
- Yellow 560 Dye: Currently an exciting clinical trial, this dye stains cancerous tissues through fluorescence to illuminate the border between normal brain tissue and tumor tissue.
In addition to brain tumor surgery, our team offers a full array of the latest medical therapies and treatments for brain tumors. Our neuro-oncology experts direct the administration of chemotherapy. Standard chemotherapy treatments are offered in keeping with evidence-based medicine. We also offer a number of promising new treatments through our involvement in clinical trials.
Leading Edge Research
The NorthShore Neurological Institute is involved in multiple clinical trials designed to offer patients promising new methods of cancer detection and treatment. Our brain tumor experts have led and participated in numerous pivotal studies that are transforming the spine and brain tumor care of our patients—and of patients elsewhere in the world.
NorthShore patients have access to clinical trials and treatment options that are not available at any other hospital in the region. In fact, more than one third of our patients are referred from well beyond our service area, both from locations across the country and internationally.
Through leading edge research and innovative technologies, our team is able to maximize outcomes for even the most complicated spine and brain tumor cases.
We offer an extensive offering of neuro-oncology trials and studies, including:
- A study to evaluate whether the addition of a vaccine to bevacizumab can improve overall survival of patients with resectable recurrent glioblastoma.
- A study to determine how the drug ABT-414 works in the body and evaluate its safety with newly diagnosed or recurrent glioblastoma patients.
Please call 877.570.7020 for more information on brain tumor symptoms and treatment, or to schedule an appointment with one of our specialists.